These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1107575)

  • 1. Suppression of an AKR lymphoma by antibody and chlorambucil.
    Ghose T; Guclu A; Tai J
    J Natl Cancer Inst; 1975 Dec; 55(6):1353-7. PubMed ID: 1107575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined effect of drugs and tumor-specific antibodies in protection against a mouse lymphoma.
    Davies DA
    Cancer Res; 1974 Nov; 34(11):3040-3. PubMed ID: 4418406
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunochemotherapy of cancer with chlorambucil-carrying antibody.
    Ghose T; Norvell ST; Guclu A; Cameron D; Bodurtha A; MacDonald AS
    Br Med J; 1972 Aug; 3(5825):495-9. PubMed ID: 4560726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice against syngeneic lymphomata: II. Collaboration between drugs and antibodies.
    Davies DA; Buckham S; Manstone AJ
    Br J Cancer; 1974 Oct; 30(4):305-11. PubMed ID: 4217194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies as carriers of radionuclides and cytotoxic drugs in the treatment and diagnosis of cancer.
    Ghose T; Tai J; Guclu A; Norvell ST; Bodurha A; Aquino J; MacDonald AS
    Ann N Y Acad Sci; 1976; 277(00):671-89. PubMed ID: 1069566
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies as carriers of anticancer agents.
    Rubens RD
    Lancet; 1974 Mar; 1(7856):498-9. PubMed ID: 4131895
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific targeting of chlorambucil to tumors with the use of monoclonal antibodies.
    Smyth MJ; Pietersz GA; Classon BJ; McKenzie IF
    J Natl Cancer Inst; 1986 Mar; 76(3):503-10. PubMed ID: 3456464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytosis of chlorambucil-bound anti-tumor globulin following "capping" in EL4 lymphoma cells.
    Guclu A; Tai J; Ghose T
    Immunol Commun; 1975; 4(3):229-42. PubMed ID: 1100518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active immunoprophylaxis and immunotherapy in two mouse lymphoma models.
    Ghose T; Guclu A; Tai J; Norvell ST; MacDonald AS
    J Natl Cancer Inst; 1976 Aug; 57(2):303-15. PubMed ID: 794497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo suppression of EL 4 lymphomas by rabbit antitumor sera.
    Ghose T; Guclu A; Faulkner J; Tal J
    J Natl Cancer Inst; 1977 Mar; 58(3):693-700. PubMed ID: 839564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of murine lymphoma and melanoma cells by chlorambucil-antibody complexes.
    De Weger RA; Dullens HF; Den Otter W
    Immunol Rev; 1982; 62():28-45. PubMed ID: 7042539
    [No Abstract]   [Full Text] [Related]  

  • 12. Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice.
    Bortin MM; Truitt RL; Rose WC; Rimm AA; Saltzstein EC
    Adv Exp Med Biol; 1976; 73 Pt B():331-9. PubMed ID: 793340
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo and in vitro effects of tumour specific antibodies with chlorambucil.
    Davies DA; O'Neill GJ
    Br J Cancer Suppl; 1973 Aug; 1():285-98. PubMed ID: 4548355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoprophylaxis and immunotherapy of EL4 lymphoma.
    Ghose T; Guclu A; Tai J; Mammen M; Norvell ST
    Eur J Cancer (1965); 1977 Sep; 13(9):925-35. PubMed ID: 913475
    [No Abstract]   [Full Text] [Related]  

  • 15. F1 resistance to AKR lymphoma cells in vivo and in vitro.
    Schmitt-Verhulst A-M ; Zatz MM
    J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of chlorambucil with antitumor globulins and its effect on drug and antibody activities.
    Guclu A; Ghose T; Tai J; Mammen M
    Eur J Cancer (1965); 1976 Feb; 12(2):95-100. PubMed ID: 4329
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of immunization on the spread of transplanted mouse lymphoma cells.
    Klein E
    J Natl Cancer Inst; 1973 Dec; 51(6):1991-2. PubMed ID: 4587755
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection of mice against syngeneic lymphomata: I. Use of antibodies.
    Davies DA; Manstone AJ; Buckham S
    Br J Cancer; 1974 Oct; 30(4):297-304. PubMed ID: 4217193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the in vitro cytotoxicity of chlorambucil by monoclonal antibodies.
    Smyth MJ; Pietersz GA; McKenzie IF
    J Immunol; 1986 Nov; 137(10):3361-6. PubMed ID: 3772105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters of serum complement in relation to tumor therapy.
    Drake WP; Mardiney MR
    Biomedicine; 1974 May; 21(5):206-9. PubMed ID: 4433667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.